相关实验视频

Updated: May 11, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

混合体体外膜氧化中的死亡率和并发症:初始使用与过渡的元分析

Irin Shin¹, Haein Ryu², Yujeong Hou²

¹From the Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South Korea.

ASAIO journal (American Society for Artificial Internal Organs : 1992)

|February 13, 2025

概括

过渡到混合体外膜氧化 (ECMO) 不会增加死亡率相比开始混合ECMO. 然而,混合ECMO可能会出现更高的并发症率,特别是脏问题,需要仔细考虑.

科学领域:

心血管医学心血管医学
肺部病理学肺部病理学
关键的护理关键的护理

背景情况:

混合体外膜氧化 (ECMO) 是一种正在发展中的严重心肺衰竭治疗方法.
随着病情的进展,患者可以启动非混合ECMO并过渡到混合ECMO.

研究的目的:

为了比较最初使用混合ECMO的患者与从非混合过渡到混合ECMO的患者之间的死亡率.
评估和比较混合和非混合ECMO之间的并发症率.

主要方法:

来自PubMed,Embase和Cochrane数据库的数据的元分析.
使用Peto概率比率和95%置信区间进行统计分析.
包括体外生命支持组织的注册数据,以提高安全性比较.

主要成果:

在初始混合ECMO和过渡混合ECMO组之间没有观察到死亡率的显著差异.
在混合和非混合ECMO中,脏并发症是最常见的.
与非混合ECMO相比,混合ECMO的整体并发症率较高.

结论:

过渡到混合ECMO不会对死亡率结果产生不利影响.
临床医生必须权衡混合ECMO的好处与其增加的并发症潜力,特别是脏问题.
这项研究为在临床实践中选择适当的ECMO策略提供了指导.

关键词:

临床影响临床影响这是一个复杂的并发症.这是一个混合ECMOECMO.死亡率死亡率

更多相关视频

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

相关概念视频

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...